A High Probability FDA-Approval Candidate For October

An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why Approval Looks Likely.

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...
Cafemutual

Debt Outlook – October 2025

Avnish Jain, Head Fixed Income, Canara Robeco AMC, Hardik Shah, Senior Fund Manager - Fixed Income, Axis MF, Pratik Shroff, Fund Manager – Debt, LIC MF and Siddharth Chaudhary, Head – Fixed Income, ...
STAT

Warning: Serious cardiovascular events don’t come out of the blue

Study finds 99% of all heart attacks, heart failure, or strokes occur in people with "suboptimal" blood pressure, cholesterol ...